deferoxamine has been researched along with folic acid in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (36.84) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Löhr, GW | 1 |
| Festa, RS | 1 |
| Vadász, G | 1 |
| Brunström, GM; Fielding, J; Karabus, C | 1 |
| Lukens, JN; Neuman, LA | 1 |
| Bannerman, RM; Keusch, G; Kreimer-Birnbaum, M; Vance, VK; Vaughan, S | 1 |
| Green, MA; Lee, RJ; Low, PS; Mathias, CJ; Wang, S; Waters, DJ | 1 |
| Baggott, JE; Cornwell, PE; Eto, I; Johanning, GL; Robinson, CB | 1 |
| Green, MA; Low, PS; Mathias, CJ; Wang, S; Waters, DJ | 1 |
| Pace, L; Palagiano, A | 1 |
| BORCHERS, HG; SCHAUER, A; SCOVILLE, B | 1 |
| Green, MA; Laforest, R; Lewis, JS; Lewis, MR; Low, PS; Mathias, CJ; Reichert, DE; Sharp, TL; Snyder, PW; Waters, DJ; Welch, MJ; Yang, ZF | 1 |
| Ibrahim, MA; Isah, MB | 1 |
| Blower, PJ; Li, N; Pham, TT; Yan, R; Yu, Z | 1 |
| Karimi Shervedani, R; Rahsepar, FR; Samiei Foroushani, M; Torabi, M; Yaghoobi, F | 1 |
4 review(s) available for deferoxamine and folic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Sideroblastic anemias].
Topics: Anemia, Sideroblastic; Bone Marrow Cells; Deferoxamine; Female; Ferritins; Ferrochelatase; Folic Acid; Heme; Hemosiderosis; Humans; Male; Precancerous Conditions; Pyridoxine; Transfusion Reaction; Vitamin B Deficiency | 1978 |
Modern management of thalassemia.
Topics: Adolescent; Arrhythmias, Cardiac; Ascorbic Acid; Blood Transfusion; Child; Cholelithiasis; Deferoxamine; Endocrine System Diseases; Female; Folic Acid; Growth Disorders; Heart Failure; Hematopoiesis; Humans; Iron; Leg Ulcer; Liver Diseases; Male; Pericarditis; Splenectomy; Thalassemia; Vitamin E | 1985 |
The role of antioxidants treatment on the pathogenesis of malarial infections: a review.
Topics: Acetylcysteine; Antimalarials; Antioxidants; Ascorbic Acid; Deferoxamine; Folic Acid; Humans; Malaria; Oxidative Stress; Plasmodium; Vitamin E | 2014 |
15 other study(ies) available for deferoxamine and folic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
[A case of Diamond-Blackfan anemia: Experiences of 10-year follow-up study].
Topics: Adolescent; Anemia, Aplastic; Biopsy; Blood Transfusion; Child; Child, Preschool; Deferoxamine; Erythrocytes, Abnormal; Erythropoiesis; Folic Acid; Follow-Up Studies; Hemosiderosis; Hepatomegaly; Humans; Immunosuppressive Agents; Liver; Long-Term Care; Male; Methyltestosterone; Prednisolone; Prognosis; Remission, Spontaneous; Splenomegaly; Syndrome | 1974 |
effect of small doses of iron on desferrioxamine chelation in iron-deficiency anaemia: evidence for ineffective erythropoiesis.
Topics: Anemia, Hypochromic; Deferoxamine; Erythropoiesis; Female; Fluorescent Antibody Technique; Folic Acid; Humans; Iron; Male; Vitamin B 12; Xylose | 1968 |
EXcretion and distribution of iron during chronic deferoxamine therapy.
Topics: Anemia, Aplastic; Bone Marrow; Bone Marrow Examination; Child; Chromium Isotopes; Deferoxamine; Folic Acid; Heart Failure; Hemosiderosis; Humans; Iron; Iron Chelating Agents; Liver; Male; Mononuclear Phagocyte System; Oxymetholone; Prednisone; Pyridoxine; Spleen; Splenectomy; Tissue Extracts; Transfusion Reaction; Vitamin B 12 | 1971 |
Thalassemia intermedia, with iron overload, cardiac failure, diabetes mellitus, hypopituitarism and porphyrinuria.
Topics: Adult; Blood Transfusion; Deferoxamine; Diabetes Mellitus; Folic Acid; Folic Acid Deficiency; Heart Failure; Hemochromatosis; Humans; Hypopituitarism; Iron; Male; Porphyrins; Splenectomy; Thalassemia | 1967 |
Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate.
Topics: Animals; Carrier Proteins; Deferoxamine; Endocytosis; Folate Receptors, GPI-Anchored; Folic Acid; Male; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Radionuclide Imaging; Receptors, Cell Surface; Tissue Distribution; Tumor Cells, Cultured | 1996 |
Iron compounds catalyze the oxidation of 10-formyl-5,6,7,8 tetrahydrofolic acid to 10-formyl-7,8 dihydrofolic acid.
Topics: Animals; Apoproteins; Ascorbic Acid; Cattle; Citric Acid; Deferoxamine; Folic Acid; In Vitro Techniques; Iron Chelating Agents; Iron Compounds; Leucovorin; Oxidation-Reduction; Spectrophotometry, Ultraviolet; Transferrin | 1998 |
Receptor-mediated targeting of 67Ga-deferoxamine-folate to folate-receptor-positive human KB tumor xenografts.
Topics: Animals; Biomarkers, Tumor; Carrier Proteins; Deferoxamine; Dose-Response Relationship, Radiation; Folate Receptors, GPI-Anchored; Folic Acid; Gallium Radioisotopes; Humans; Isotope Labeling; KB Cells; Male; Mice; Mice, Nude; Radiopharmaceuticals; Receptors, Cell Surface; Tissue Distribution | 1999 |
[Pregnancy in women with thalassaemia].
Topics: Adult; Blood Transfusion; Chelating Agents; Deferoxamine; Female; Folic Acid; Hematinics; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Hematologic; Prenatal Care; Thalassemia | 2001 |
[ERYTHROBLASTOPHTHISIS].
Topics: Adrenal Cortex Hormones; Androgens; Blood Cell Count; Blood Transfusion; Deferoxamine; Electrocardiography; Folic Acid; Heart Failure; Humans; Iron; Liver Cirrhosis; Pathology; Physiology; Riboflavin; Surgical Procedures, Operative; Thalassemia; Thymectomy; Vitamin B 12 | 1964 |
Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals.
Topics: Animals; Autoradiography; Carrier Proteins; Deferoxamine; Feasibility Studies; Fluorodeoxyglucose F18; Folate Receptors, GPI-Anchored; Folic Acid; Gallium Radioisotopes; Humans; Isotope Labeling; KB Cells; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Radiopharmaceuticals; Receptors, Cell Surface; Tomography, Emission-Computed | 2003 |
A generic
Topics: Animals; Deferoxamine; Drug Stability; Female; Folic Acid; Humans; Isotope Labeling; Liposomes; Mice; Mice, Nude; Nanoparticles; Positron-Emission Tomography; Quinolinic Acid; Radioisotopes; Radiopharmaceuticals; Rats; Tissue Distribution; Xenograft Model Antitumor Assays; Zirconium | 2017 |
Controlled synthesis of mixed molecular nanostructures from folate and deferrioxamine-Ga(III) on gold and tuning their performance for cancer cells.
Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Deferoxamine; Drug Delivery Systems; Female; Folic Acid; Gallium; Gold; Mice; Nanostructures; Nanotechnology; Theranostic Nanomedicine | 2018 |